From nonalcoholic steatohepatitis, metabolic dysfunction-associated fatty liver disease, to steatotic liver disease: Updates of nomenclature and impact on clinical trials
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Korean Association for the Study of the Liver
2023-10-01
|
| Series: | Clinical and Molecular Hepatology |
| Subjects: | |
| Online Access: | http://e-cmh.org/upload/pdf/cmh-2023-0359.pdf |
| _version_ | 1797661338896433152 |
|---|---|
| author | Ming-Lun Yeh Ming-Lung Yu |
| author_facet | Ming-Lun Yeh Ming-Lung Yu |
| author_sort | Ming-Lun Yeh |
| collection | DOAJ |
| first_indexed | 2024-03-11T18:44:02Z |
| format | Article |
| id | doaj.art-b36d26fe8d734890b289cc284f9d45fa |
| institution | Directory Open Access Journal |
| issn | 2287-2728 2287-285X |
| language | English |
| last_indexed | 2024-03-11T18:44:02Z |
| publishDate | 2023-10-01 |
| publisher | Korean Association for the Study of the Liver |
| record_format | Article |
| series | Clinical and Molecular Hepatology |
| spelling | doaj.art-b36d26fe8d734890b289cc284f9d45fa2023-10-12T07:11:59ZengKorean Association for the Study of the LiverClinical and Molecular Hepatology2287-27282287-285X2023-10-0129496997210.3350/cmh.2023.03591856From nonalcoholic steatohepatitis, metabolic dysfunction-associated fatty liver disease, to steatotic liver disease: Updates of nomenclature and impact on clinical trialsMing-Lun Yeh0Ming-Lung Yu1 School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwanhttp://e-cmh.org/upload/pdf/cmh-2023-0359.pdfnafldmafldsldmasldsteatosis |
| spellingShingle | Ming-Lun Yeh Ming-Lung Yu From nonalcoholic steatohepatitis, metabolic dysfunction-associated fatty liver disease, to steatotic liver disease: Updates of nomenclature and impact on clinical trials Clinical and Molecular Hepatology nafld mafld sld masld steatosis |
| title | From nonalcoholic steatohepatitis, metabolic dysfunction-associated fatty liver disease, to steatotic liver disease: Updates of nomenclature and impact on clinical trials |
| title_full | From nonalcoholic steatohepatitis, metabolic dysfunction-associated fatty liver disease, to steatotic liver disease: Updates of nomenclature and impact on clinical trials |
| title_fullStr | From nonalcoholic steatohepatitis, metabolic dysfunction-associated fatty liver disease, to steatotic liver disease: Updates of nomenclature and impact on clinical trials |
| title_full_unstemmed | From nonalcoholic steatohepatitis, metabolic dysfunction-associated fatty liver disease, to steatotic liver disease: Updates of nomenclature and impact on clinical trials |
| title_short | From nonalcoholic steatohepatitis, metabolic dysfunction-associated fatty liver disease, to steatotic liver disease: Updates of nomenclature and impact on clinical trials |
| title_sort | from nonalcoholic steatohepatitis metabolic dysfunction associated fatty liver disease to steatotic liver disease updates of nomenclature and impact on clinical trials |
| topic | nafld mafld sld masld steatosis |
| url | http://e-cmh.org/upload/pdf/cmh-2023-0359.pdf |
| work_keys_str_mv | AT minglunyeh fromnonalcoholicsteatohepatitismetabolicdysfunctionassociatedfattyliverdiseasetosteatoticliverdiseaseupdatesofnomenclatureandimpactonclinicaltrials AT minglungyu fromnonalcoholicsteatohepatitismetabolicdysfunctionassociatedfattyliverdiseasetosteatoticliverdiseaseupdatesofnomenclatureandimpactonclinicaltrials |